The prognosis and course of multiple sclerosis (MS) and the factors that affect them were assessed in a group of 1055 patients, representing an unselected (epidemiological) sample observed in the north-east (Grampian region) of Scotland for a period ranging between 1 and 60 yrs. In 7% the disease began before the age of 20 yrs, in 12% after the age of 50 yrs, and in the remainder onset was between the ages of 20 and 50 yrs. The male/female ratio was 1:1.8. Mean disease duration in those observed until death (216 patients) was 24.5 yrs, with no significant difference between the sexes. Prognosis was assessed either by the interval between onset and death or by the degree of disability over a defined period of time. Depending on the length of follow-up, just over one-quarter (26%) to over one-third (36.3%) had a benign course and between 8.0 and 17.7% had a poor prognosis. Nearly a third had a remittent (32.8%) or relapsing cumulative (34%) course and 9% had a progressive course from the start. Several factors were noted to affect the prognosis.
INTRODUCTION
There have been only a few studies analysing the prognosis and course of multiple sclerosis (MS) in patients observed for a long period and derived from a prevalence source (Allison, 1950; Hyllested, 1956; Gruber, 1962; Panelius, 1969; Gudmundsson, 1971; Percy et al., 1971; Leibowitz and Alter, 1973; Broman et al., 1981; Poser et al., 1982a) and only one of these (Broman et al., 1981) was based on a prospective analysis. Studies based on a selected group of MS patients observed in a hospital have been many (Millar, 1949; Miiller, 1949; Carter et al., 1950; Ipsen, 1950; Lazarte, 1950; MacLean and Berkson, 1951; McAlpine and Compston, 1952;  Correspondence to: Dr J. G. Phadke, 74 Vasudeo Nagar, Indore-452004 (MP). India. Thygesen, 1953; Abb and Schaltenbrand, 1956; McAlpine, 1%1, 1964; Lehoczky et al., 1963; Poeck and Markus, 1964; Bauer et al., 1965; Bonduelle, 1967; Fog and Linnemann, 1970; Riser et al., 1971; Kurtzke etai, 1977; Confavreux etal, 1980; Noseworthy et al., 1983; Verjans et al., 1983; Thompson et al., 1986) , the majority of these have been retrospective and often biased towards patients at the severe end of the disease spectrum.
The US male war veterans study (Kurtzke et al., 1977) , although not on a prevalence sample, did encompass a clearly defined population and with some reservations could be considered as representative of the disease in that group. Miiller (1949) analysed a fairly large representative sample of patients attending hospital in Stockholm but diagnostic facilities during the period of the study were not well developed and it is likely that a proportion of his cases may not have had MS. McAlpine and Compston's (1952) and McAlpine's (1961 McAlpine's ( , 1964 often quoted classical study did represent a large sample but it was probably on a selected group of patients attending hospital biased towards the severe end of the disease spectrum, as suggested by the short mean survival period of 11 yrs.
The north-east of Scotland has been under close epidemiological scrutiny for MS since 1970. Three major surveys have been carried out in the region between 1970 (Shepherd and Downie, 1978 Phadke and Downie, 1987) . In 1970, besides analysing the incidence and prevalence of MS, a register was also established. The clinical and laboratory information for all patients seen subsequently was recorded on index cards and periodically updated. Mortality data were collected periodically and have been reported elsewhere (Phadke, 1987) .
Some of the clinical features of the disease noted in the 1970 survey have been documented previously (Shepherd, 1979) . On the basis of the information collected during the latest survey (Phadke, 1985) a further analysis of the clinical features was undertaken. Data have been generated about the natural history of the disease which should prove helpful in counselling MS patients.
Very few authors have attempted to compare the different clinical features, in particular, the course and prognosis of MS in different parts of the world (Poser, 1978; Shibasaki etal., 1981; Kuroiwa and Kurland, 1982) . Many difficulties exist in carrying out such a comparison. These include differences in diagnostic criteria, analysis of a selected sample with its inherent drawbacks-often from an inpatient source only, and frequently biased towards the severe end of the disease spectrum, or with a small sample size often followed for a short period and often analysed retrospectively; and, finally, lack of uniformity in the definitions of various clinical parameters such as course, prognosis, relapse, etc.
It has been observed that MS in eastern centres such as Japan (Kuroiwa et al., 1975) , Taiwan (Hung et al., 1976) , China (Baoxun et al., 1982) and India (Mathew et al., 1971) , presents differently with a much higher frequency of early, severe, and often bilateral optic neuritis and with a male preponderance. Comparison of certain clinical aspects of the disease amongst western centres has been attempted twice (Poser, 1978; Shibasaki et al., 1981) but precise conclusions could not be reached. A further comparison, including findings of the present sample, has been undertaken in the latter half of this paper.
MATERIAL AND METHODS
Details of the incidence and prevalence of MS in the region have been published elsewhere (Shepherd and Downie, 1978, 1980; Phadke and Downie, 1987) . During the final survey (Phadke and Downie, 1987) , other than the demographic data, a number of clinical and laboratory details were stored on a mainframe computer. Data were recorded initially on index cards for all individuals known at the 1970 survey and subsequently until 1981. Information on these cards was regularly updated on the basis of letters from the hospital visits, from the case notes, VEP register, personal examination of all chronically hospitalized patients and from the questionnaire answered by all the general practitioners of the region during the three postal surveys. The last of the above sources provided information regarding the current state of disability and the number of relapses since the last hospital visit.
The questionnaires were on a standard proforma which contained, amongst other things, an abbreviated form of the McAlpine's disability scale as a guide line. Based on the total available information, patients were classified using modified criteria of Allison and Millar (1954) . The two subdivisions of the probable category of these criteria were merged into one for convenience; thus 'probable' MS included patients with a history and physical signs of CNS disease, disseminated in time and site of involvement, in whom other neurological conditions had been excluded so far as possible. Also included in this category were patients seen at an earlier stage of the disease with a clear history of remission and relapses but with few physical signs of a CNS lesion, and in whom the clinical diagnosis of MS was supported by laboratory evidence such as a raised percentage concentration of IgG in the CSF, prolonged VEP P100 latency or a periventricular low density area on CT scan of the brain. The criteria for the 'possible' category were similar to those given by Allison and Millar; thus the 'possible' category included those with clinical findings compatible with MS in whom other diagnoses had been excluded so far as possible; in some of these, evidence of multiplicity of lesions was, however, lacking. This category also included some patients with a late onset progressive spastic paraparesis in whom full investigations, including myelography, had excluded other likely causes of such a clinical picture.
The above categorization of the patients was carried out in joint consultation with Dr A. W. Downie, who had been closely involved in the local MS project since its inception. Patients with isolated optic neuritis and those with diagnostic uncertainty on clinical grounds were excluded. The degree of disability amongst those living at the time of the latest survey (1981) was combined with the duration of the disease to form 7 prognostic categories, McAlpine and Compston's (1952) disability grading was used. Those who died between the years 1970 and 1981 were grouped under a separate-eighth-category. The classification of Confavreux el al. (1980) was used as a basis for the following 8 prognostic groups.
1. Benign. Patients with the least severity, who had no disability at 10 or more yrs after the onset of MS, or who had grade II disability at 15 yrs and above.
2. Moderate. Patients with a disability of grade III and above and a disease duration exceeding 30 yrs. 3. Intermediate. Patients with a disability of grade III and above and a disease duration ranging between 21 and 30 yrs.
4. Subacute. Patients with a disability of grade III and above and a disease duration ranging between II and 20 yrs.
5. Acute. Patients with a disability of grade III and above and a disease duration ranging between 6 and 10 yrs.
6. Hyperacute. Patients at the most severe end of the disease spectrum, who had disability of grade III and above within 5 yrs of the onset of the disease.
7. Unclassified. Patients with either no disability but with a relatively short disease duration under 10 yrs, or a minimal disability (grade II) at 15 yrs from the onset.
8. Dead. All deaths from the patients identified in the first survey (1970) , and also those diagnosed until the third survey (1981), numbering 216 patients. The clinical details of this group including the influence of various factors on the period of survival have been published elsewhere (Phadke, 1987) .
In addition to analysing the prognosis of the 1055 patients identified in the 1970 and/or 1981 surveys in the above manner, an unselected group of 672 patients observed for over 10 yrs was evaluated separately. This subgroup represented an unselected (prevalence) sample of those patients who lived in the region at the 1970 survey and whose prognosis in terms of the extent of morbidity or mortality until 1981 was known. The purpose of this separate analysis was to assess the prognostic value of the degree of disability at a point in time for an unselected cohort of patients observed for a reasonably long period in excess of 10 yrs.
The course of the disease from the onset to the point of the latest survey was analysed separately for the total 1055 patients, based on the classifications of Confavreux et al. (1980) and Poser et al. (1982A) . The following four categories were made.
1. Remittent. Those in whom the disease was in complete remission without any resultant disability at the time of the latest survey, or until just before death amongst those observed until then.
2. Relapsing cumulative. Patients who had a stepwise increase in the disability following each relapse until the time of the latest survey, or just before death among those observed until then.
3. Relapsing progressive. Those in whom the initial disease pattern was remitting-relapsing in nature followed later by relentlessly progressive increase in disability until the time of the latest survey, or until death in those observed until then.
4. Progressive. Those in whom the disability inexorably increased without remission between onset to the point of the latest survey or until the time of death in those observed until then.
McAlpine 's (McAlpine and Compston, 1952) definitions for onset of the disease, relapse and remission were adhered to.
The CSF IgG was estimated using agar gel electrophoresis and results were expressed as a percentage of the total protein in the CSF. VEPs were recorded using pattern reversal at 1/s averaging 128-256 sweeps for each eye separately. The following clinical and laboratory parameters were correlated with the prognosis and course using a mainframe computer to assess the predictive value of each of these parameters. (1) Age at onset; (2) sex; (3) address at onset of the disease and during childhood; (4) presence or absence of a family history of MS; (5) social class at the onset of MS; (6) occupation at onset; (7) pattern of initial symptoms; (8) whether the onset was monosymptomatic or polysymptomatic; (9) anatomical site of the initial CNS lesion diagnosed on clinical grounds; (10) duration of the initial symptoms; (11) interval between onset and the first relapse (O-R interval); (12) VEP P100 latency; (13) CSF findings including percentage IgG; and (14) changes on the CT brain scan.
The x 2 test, or Mann-Whitney U test were used to assess the level of significance. Appropriate correction in P value was carried out in multiple group comparisons.
Comparison of the worldwide clinical pattern of MS
Publications prior to 1949 were excluded because of a relatively small number of patients or nonavailability of precise clinical information about patients in most instances. All cases were included in each study, irrespective of their diagnostic category. Studies satisfying the following criteria were included.
1. Those studies where precisely defined diagnostic criteria were adhered to. 2. Those in which the patients were identified during a epidemiological survey or where they represented an unselected series of MS patients attending hospital or where the author(s) showed convincingly that the sample, albeit small, was representative of the disease in that region of the world. This latter point particularly applied to reports from the eastern centres.
3. Those studies where a sizeable number of patients had been observed for a period in excess of 10 yrs or where the interval between two epidemiological surveys was sufficiently long.
Figures from certain studies had to be rearranged to allow comparison. The following clinical parameters were compared.
1. Age at onset-this was grouped into three: those under 20 yrs, those between 20 and 50 yrs and those over 50 yrs. Studies using Schumacher's diagnostic criteria (Schumacher et al., 1965) were therefore excluded because of their imposed restrictions.
2. Sex distribution. 3. Frequency of various initial neurological symptoms. These were grouped under seven broad categories, viz, cerebral disturbance, e.g., seizures, hemiplegia with facial involvement, dysphasia, psychoses, etc.; retrobulbar neuritis; brainstem disturbances; cerebellar involvement; pyramidal involvement; sensory tract disturbances; and disturbances of micturition, e.g., precipitancy, incontinence or retention of urine.
4. Anatomical site(s) of initial lesion(s). The available information as to the initial localization was grouped under 8 anatomical sites as for the present sample.
5. Course of the disease. In only a few studies was such information available. Patients were grouped under the three categories, i.e., remittent-relapsing, relapsing-progressive and progressive, as defined previously for the present sample. In certain studies patients were grouped into only two categories, i.e., relapsing-remitting and progressive; data from these were analysed separately.
6. Prognosis of the disease. This was judged by combining the degTee of disability with the duration of the disease between onset to the year of the study or by the mean period of survival. To bring uniformity into the analysis of the degree of disability in various studies, comparison made by Detels et al. (1982) of the various commonly used disability grading systems was used as a guideline, after a few modifications.
The following five prognostic categories, different from those used for the present sample, were made because only limited information as to the degree of disability and duration was available in most published series.
1 
RESULTS

Present series
Duration of the disease amongst the 1055 patients known to exist between 1970 and 1980 ranged between 1 and 60 yrs. The male to female ratio was 1:1.8 (M = 372; F = 683).
Age at onset
Over three-quarters of the patients had an onset of the disease between the ages 20 and 50 yrs, 12% had an onset after the age of 50 yrs, and in 7% it was under the age of 20 yrs ( fig. 1 ). 
Prognostic categories
Out of the 1055 patients, just over a quarter had a benign prognosis. At the other end of the disease spectrum, only 8% fell into the hyperacute and acute prognostic categories; a fifth of the patients died during the period between 1970 and 1981, with a mean period of 24.5 yrs between onset and death. There was no statistically significant difference between males and females in the proportion of patients in the various prognostic categories, or in the period of survival. Just over a fifth were grouped under the unclassified prognostic category because of the relatively short period of observation (Table 1) . This large number of patients observed for a short period naturally influenced significantly the overall proportion of patients in the other prognostic categories.
To overcome the drawback of a rather short observation period, the 1970 cohort {see Methods) was assessed separately. Analysis of these 672 patients (forming part of the total of 1055 patients) who were present in the region in 1970 and whose disease outcome after 10 yrs (in 1981) was known, is shown in Table 2 .
Over one-third of the patients (36.9%) from this cohort had a benign prognosis (Category 1). Of those who were unrestricted in 1970 (McAlpine's disability grade 1) about three-quarters (71.8%) remained so in 1980. Just over a quarter (29.9%) of those with various other worse grades of disability in 1970 were dead by 1980. Of the 35 patients confined to bed, and of the 98 confined to a wheelchair in the year 1970, 85% and 68%, respectively, had died by 1980.
Course of the disease
Out of the 1055 patients in whom the disease course was known, in a third the disease had a remitting and relapsing cumulative pattern, in 9% it was progressive from the McAlpine's disability grades (McAlpine and Compston, 1952 ) (abbreviated form): I = unrestricted but not necessarily asymptomatic; II = partly restricted but able to walk unaided; III = markedly restricted-walking with aids outdoors; IV = housebound-mobile at home only, with support; V = wheelchair bound; VI = bed bound-requiring total care. start, and in 22% the disease entered a progressive phase by the time of the latest survey in 1981, after an initially relapsing-remitting pattern (Table 3) .
Prognosis and course and their relationship to various clinical and laboratory variables
When correlating various clinical and laboratory variables with the disease prognosis and course, the problem of lack of information on all aspects of the disease for every patient arose. As a result, with the exception of judging the influence of the age at onset on the course and the prognosis of the disease, and of the course on the prognosis in nearly the whole of the present sample, the influence of the remaining clinical and laboratory parameters was confined to those living in the region at the time of the latest survey in 1981. The numbers in whom correlation between various parameters was possible is shown as the denominator in figs 3-6 and Tables 4-8.
Prognosis and course of the disease by sex. No significant difference was noted between males and females, either in the pattern of the course or the prognosis of the disease.
Prognosis and course of the disease by age at onset. Prognosis could be correlated with the age at onset in 1039 patients ( fig. 2 ): the younger the age, the better was the prognosis, both in terms of morbidity and the period of survival. Data regarding the latter aspect are published elsewhere (Phadke, 1987) . Of those with onset under the age of 20 yrs, 43% had a benign prognosis compared with 12% of those over the age of 50 yrs; other age groups fell in between (x 2 = 73.10, df = 4, P < 0.0001). In ( fig. 3 ). The proportion of those with a progressive course either from the start or after an initially relapsing-remitting period progressively rose with age, 2.7% of those with onset under the age of 20 yrs had such a pattern compared with 26.5% of those with onset over the age of 50 yrs; the proportion of those with a remitting pattern of the disease correspondingly declined (x 2 = 91.83, df = 12, P < 0.005) ( fig. 3 ). Prognosis by initial site of the lesion. The initial site of lesion was adjudged on the basis of the initial symptoms and examination findings in 774 patients. Those with an initial isolated optic neuritis or a brainstem lesion had a significantly better prognosis {P < 0.005) (fig. 4) . In contrast, those with an initial spinal cord lesion or lesions at more than one site (mixed) had a significantly worse prognosis (P < 0.005) (fig. 4) .
On analysis of the symptoms alone, those with initial gait ataxia (172 patients), usually due to cerebellar disturbance, or those with weakness due to a pyramidal lesion (436 patients), were noted to have a significantly worse prognosis (irrespective of sex) (P < 0.002). In addition, only amongst the females, an onset with symptoms of a cerebral lesion (25 patients) or of urinary disturbance (32 patients) also signified a worse prognosis (P < 0.025 and P < 0.02, respectively).
Males and females with symptoms due to a spinothalamic disturbance, and females alone with initial symptoms of posterior column disturbance, more often had a benign prognosis, although none of these groups achieved a statistical level of significance.
Course by the initial site of lesion. This could be correlated in 773 patients. Those with initial optic neuritis, a brainstem lesion or a spinal cord lesion had a significantly higher incidence of having an initially remitting course {see fig. 5 for the level of statistical significance). In contrast, those with an initial lesion at more than one site (mixed category, fig. 5 ) more often had a progressive course from the onset or a tendency to have a cumulative disability following several initial relapses (P < 0.002) ( fig. 5 ).
Prognosis and course by duration of initial symptoms. The length for which the initial symptoms lasted could be correlated with the prognosis in the case of 607 patients. A linear and highly significant relationship was noted between the length of the initial symptom and the severity of the disease, irrespective of its nature (x 2 = 227.05, (Table 4) . Of the 274 patients with a benign prognosis, in 36.9% the initial symptoms resolved within 1 month compared with only 11.1% of those in the hyperacute and 12.2% in the acute prognostic categories. In a sizeable majority of the patients in the latter two categories (41.7% and 57.1%, respectively), the initial symptoms did not resolve even by the second year. The earlier the resolution of initial symptoms, the more likely was the disease to stay in remission for a longer period.
Of the 311 patients who were in remission, in 41.9% the symptoms had resolved by 1 month compared with 26.8% of the 233 with a relapsing cumulative, 21.4% of the 131 with a relapsive progressive and 1.6% of the 63 with a progressive course.
Onset -first relapse (O -R) interval by prognosis of the disease.
The longer the O -R interval, the better the prognosis (Table 5) . Of the 232 patients in the benign category, only one-third had the first relapse in less than 1 year compared with 70.9% of those in the hyperacute (category 6) and 44.4% of those in the acute (category 5) prognostic categories. A long O-R interval was also associated with a longer survival, for example, 55.3% of those survived over 20 yrs from the onset (moderate prognostic category) had an O -R interval exceeding 5 yrs.
Prognosis by course of the disease. This correlation was possible in 1036 patients. Of these, 346 patients had a remittent course. These were excluded because in them the prognosis was either benign (51 %) or a short follow-up did not allow the prognosis to be judged. In the other three course categories a highly significant difference was noted in the disease prognosis ( fig. 6 ). Of those with a relapsing cumulative course 26% had a benign prognosis compared with 1% of those with relapsing progressive and 4% of those with a progressive course. The proportion of those with an acute and hyperacute prognosis was correspondingly higher in those with a progressive course from the start. The differences were highly significant (x 2 = 412.2, df = 20, P < 0.0001) (Fig. 6 ). Mean duration of the disease was also shortest amongst those with a progressive course from the start; details on this aspect have been published elsewhere (Phadke, 1987) .
Relationship between the disease course and prognosis and address in childhood or at the onset of the disease, social class and the family history of MS. Residential address in childhood or at the onset of the disease had no relationship with the course or the prognosis of the disease.
Those with a family history of MS frequently had an acute prognosis, but this was not statistically significant. Those with a family history of MS had a significantly greater chance of having a progressive course from the start of the disease (P < 0.02) ( Table 6) .
Social class at the onset of the disease also had a clear relationship with the course and prognosis of the disease (Table 7) . Those from social classes I and II frequently had a benign prognosis and a remittent course as compared with those belonging to social classes IV and V who more often belonged to the acute or hyperacute prognostic categories (x 2 = 13.302, df = 4, P < 0.002), and had a progressive course from the start of the disease (x 2 = 19.4, df = 6, P < 0.03) ( Table 7) .
Relationship between VEP P100 latency and disease course and prognosis. VEPs were recorded in 349 patients. Those from the hyperacute or acute prognostic categories more often had a bilaterally delayed VEP P100 latency (P < 0.05). Most patients with (234) 100 (212) 100 (65) 100 (277) 100 (230) 100 (136) 100 ( a moderate intermediate and subacute prognosis had the disease well established for many years before the local availability of the VEP recording facilities. Of the 60 patients from these three categories in whom VEPs were recorded, a very high proportion (83.3 %) had a prolonged P100 latency, and in a majority of the cases these changes were bilateral (Table 8) . Amongst the various course categories, those with a progressive course (i.e., those with severe disease) also often had bilaterally abnormal VEP PI00 latency (P < 0.002) ( Table 8 ).
Prognosis and course by changes in the cerebrospinal fluid (CSF).
The CSF was examined in 636 patients. Changes in any of the CSF parameters had no relationship with the prognosis or the course of the disease, with the exception of an insignificant excess of those with a remittent course having a CSF pleocytosis.
Brain CT scan findings and disease course and prognosis
Ninety-seven patients had a CT brain scan on a second generation scanner. Of these, 45.6% had one or more than one abnormality such as cortical atrophy, peri ventricular low density areas, or an enhancing lesion presumed to be MS plaques. The CT scan findings had no significant relationship with the course or the prognosis of the disease. Tables 9 -11 . In Table 9 , age at onset, sex distribution and disease course have been compared; in Table 10 , the pattern of initial symptoms and of the initial anatomical site of the lesion have been compared, and in Table 11 , the prognosis in terms of disability over a period of time and the mean period of survival have been compared. Each study has been ascribed a number. The name of the centre, year of the study, author's name(s) and number of patients involved is shown either in the first or second column of each table. The diagnostic criteria used in each study are shown in the second last column in Table 9 , the observation period in the last column in Tables 9 and 11 , and the interval between two surveys (wherever they took place) is shown in the last column in Table 11 . Studies derived from a hospital source have been designated by 1 asterisk and those derived from an epidemiological source by 2 asterisks.
Worldwide comparison of clinical features of MS
Comparison of the various clinical features between different centres is presented in
Age at onset. In most centres the age at onset fell between 20 and 50 yrs. A significantly higher proportion of patients in the eastern hemispheres were, however, reported as having an onset under the age of 20 yrs. Significant differences in the age at onset were also noted amongst the western series (Table 9 , column 5). Owing to the possibility of case selection in the hospital-derived series, comparison was restricted to the series derived from epidemiological sources (designated by **); even amongst these, highly significant differences were noted between the various centres (x 2 = 33.64, df = 11, P < 0.001).
Sex distribution. Female preponderance was evident in all western series except in study 6 (Table 9 , column 6). The proportion of females varied from 53% (study 8) to 71% (study 23). Statistical analysis of the actual numbers, however, showed no significant difference between the various larger series. (46) 100 (31) 100 (42) 100 (67) 100 (72) 100 (30) 100 ( • In column 2 « studies based on hospital-attending patients only. ** In column 2 = studies based on patients from an epidemiological sample. -= Data for the item is either not mentioned or not clearly indicated in that publication. In study 2, 42 cases from a purely male source of referral have been excluded. In study 14, 9 cases with isolated retrobulbar neuritis have been excluded. Age at onset was unknown in 6% in study 4 and 2% in study 24; disease course was uncertain in 2% in study 24. 
Pattern of initial symptoms (some indicated as site of lesion) (%) Distribution by initial site of lesion in the CNS (%)
Author ( Course of the disease. Comparison on this aspect proved particularly difficult because of lack of uniformity in the definitions of the different course patterns (Table 9 , column 7). In 16 studies data on this aspect were available. Of these, in 9 the patients were grouped under two course categories, namely remittent-relapsing and progressive; in the remaining 7, an additional third category of a relapsing-progressive course was identified. In the first of these two former groups (of 9 series) the proportion of patients with a progressive course ranged between 10 and 33%. Confining the statistical analysis to this group also showed a highly significant difference in the proportion of cases with a progressive course from the onset (x 2 = 32.1, df = 5, P < 0.0001). In the second group of 5 series, the proportion of patients in the three categories also differed highly significantly (P < 0.001). A significant difference in the proportion of cases in the various course categories was also noted in the hospital-derived series (*) (P < 0.04).
Pattern of initial symptoms. This aspect could be compared between 18 series (Table  10) . Nonspecific symptoms such as headache, fatigue, etc., were excluded from the present comparison. The high frequency of initial symptoms due to optic neuritis in the eastern centres is obvious from the values in Table 10 . In several other eastern studies not shown in Table 10 a similar high frequency was also observed (Kurtzke et at., 1968a; Baoxun et al., 1982; Vejjajiva, 1982) .
On comparing the frequency of symptoms due to lesions in the brainstem, pyramidal tracts, sensory tracts, cerebellum and of urinary control, highly significant differences were noted between different centres (Table 10 ). These differences remained highly significant despite comparing separately the hospital-based with the epidemiologicallyderived series (P < 0!03 to < 0.005).
Distribution of the initial anatomical site of lesion in the central nervous system. This was adjudged by combining the neurological signs and symptoms. Only in 4 series with a sufficiently large patient sample (studies 2, 5, 13, 18) could this aspect be compared (Table 10 ). The high frequency of initial unilateral or bilateral optic neuritis noted in Taiwan (study no. 13) is strikingly obvious. Other studies from the east not shown in Table 10 have revealed similar findings (Gouri-Devi and Nagaraja, 1982; Renales et al., 1982; Vejjajiva, 1982) . A significant difference was also noted in the frequency of lesions at other sites. In the present series (study no. 18, Table 10), a high frequency of an initial brainstem lesion was noted compared with the Welsh and the West German series. In contrast, in the German series (study no. 5), a higher number of patients seemed to have initial lesions at multiple sites. Similar data from other centres with unselected patient samples are needed before firm conclusions on this aspect of the disease can be drawn.
Prognosis of the disease
The degree of disability over a period of time (often analysed retrospectively) was known for 30 series, and the mean duration between onset to death was known for 21 centres. On comparing the 10 series derived from epidemiological sources separately (designated by **) a highly significant difference was noted (P < 0.005). On splitting these 10 series into three groups, i.e., those where the prognosis was assessed between two prevalence surveys (Table 11, studies 15, 21-23, 29, 30) , those where it was assessed retrospectively at a point prevalence study (study nos. 19, 20, 28) , and thirdly, those where it was assessed prospectively (study no. 22), a highly significant difference was noted in the severity of the disease in each of the three groups.
On comparing separately the hospital-based series (designated by an asterisk in Table  11 ) a significant difference in the prognosis of the disease in patients from different centres was also noted (P < 0.005). In keeping with the generally held belief, the proportion of cases in the benign category was generally lower in the hospital-derived group (range 8-32%), and that in the severe category was generally higher (range 16 -31%) compared with most of the epidemiologically-derived samples.
The mean period of survival (the interval between onset and death) was known for patients from 21 centres. This was less than 15 yrs in most studies from the preantibiotic era. Series published in the last 30 yrs showed widely diverse figures ranging from 17.4 yrs (study 2, Table 11 ) to 29 yrs (study 14); the majority of the studies in this period, however, showed a mean survival period around 25 yrs with the exception of those from Winnipeg (study 18) and Israel (study 2) where a reason for a shorter survival period is not apparent.
In the solitary eastern study, where mortality amongst 256 Chinese patients was analysed retrospectively, a much more severe prognosis was noted (Baoxun et al., 1982) . In this group, of the 19 patients who died during the observation period ranging between 7 and 30 yrs, 11 died within 2 yrs of onset; of those who were alive, all those remaining, apart from 5%, became moderately to severely disabled within 10 yrs of onset. These figures support the generally held belief that MS in the eastern hemisphere has a more severe prognosis as compared with the west; this, however, needs confirmation with data from other eastern centres.
DISCUSSION
As noted in Table 11 , duration of the disease, disability at a point in time, or disability between two surveys have all been used as measures of the severity of the disease. More recently, disability at a point in time combined with disease duration has been used as a 'disability index' to assess the prognosis (Poser et al., 1982a; Verjans et al., 1983; Visscher et al., 1984) . With the exception of a few studies (Allison, 1950; Gruber, 1962; McAlpine, 1964; Leibowitz and Alter, 1973; Kurtzke etal., 1977; Confavreux et al., 1980) , most studies have been retrospective, often involving selected and small numbers of patients, usually followed in a hospital because of the severe nature of the disease.
Every system of evaluation has some drawback. Ideally, a longitudinal follow-up of a large cohort of an unselected sample observed from the onset to death would probably give the best idea of disease prognosis. However, the logistics of such an exercise are phenomenal and are usually beyond the scope of a general neurological department. The present study, constituting a close follow-up of an epidemiological sample identified in a prevalence survey, is the closest approach to this ideal. The prognostic classification of Confavreux et al. (19980) was found to be well suited to deal with a particularly large sample such as this. Although McAlpine's disability grading system gives only a broad and overall view of the degree of disability, it was found to be simple and reliable, and particularly well suited for obtaining information about the current disability status of the present sample through a postal survey of the general practitioners of the region. Attempts to identify genetic or immunological host factors which could predict the natural history of the disease have not been fruitful. However, various clinical features of the disease which could predict the course and prognosis have been evaluated. Amongst these, age at onset, sex, and pattern of symptoms at the onset have received the greatest attention. In the present study a number of additional features were analysed, some of which were of predictive value. The following features were associated with a good prognosis: younger age at onset; negative family history of MS; higher social class; certain initial features such as the occurrence of a brainstem lesion or optic neuritis; shorter duration of the initial symptoms; a longer interval between the initial symptoms and the first relapse; and normal or only unilaterally prolonged VEP PI00 latency. The prognosis was also significantly better in those with an initially remittent course. Factors which proved to be of no predictive value were sex, address in childhood or at the onset of the disease, changes in the CT brain scan, and CSF findings, including percentage IgG concentration.
The better prognosis associated with a younger age at onset has been noted by the majority of authors (Miiller, 1949; Ipsen, 1950; Hyllested, 1961; Poeck and Markus, 1964; Stazio et al, 1964; Bonduelle, 1967; Gudmundsson, 1971; Riser etal., 1971; Leibowitz and Alter, 1973; Kurtzke et al, 1977; Confavreux et al., 1980; Broman etal., 1981; Clark et al, 1982; Poser etal., 1982ft; Noseworthy etal., 1983; Verjans et al., 1983; Visscher et al, 1984; Thompson et al., 1986) . What is the likely basis of this age-related difference in the prognosis? It is possible that this may just be a function of ageing, as observed, for example, in the context of cerebrovascular disease. Another possibility is that it reflects age-related differences in the behaviour of the immune system. Alteration of T cell function in MS has been demonstrated (Compston, 1983) but age-related differences have yet to be analysed and may prove to be of interest.
Age also clearly influences the course of the disease. The finding in the present study that older patients more often have a progressive course from the start is in keeping with observations in most centres (McAlpine and Compston, 1952; Poeck and Markus, 1964; Leibowitz and Alter, 1973; Confavreux etal, 1980; Poser etal., 1982ft; Thompson et al., 1986) . In addition, amongst these patients there was also a clear trend of early entry to the progressive phase after an initially relapsing-remitting pattern. Miiller (1949) , in his retrospective analysis, also observed a similar relationship.
The lack of a significant influence of the patients' sex on the prognosis of the present sample has been observed previously by many (Miiller, 1949; Hyllested, 1956; Panelius, 1969; Gudmundsson, 1977; Broman et al., 1981; Visscher et al, 1984) .
As in the present series, Miiller (1949) , Abb and Schaltenbrand (1956) , McAlpine (1961) , Poeck and Markus (1964) and Panelius (1969) also found a more benign prognosis after an initial brainstem lesion, and Abb and Schaltenbrand (1956) , McAlpine (1961) and Wikstrom et al. (1980) have also noted a similar association with an initial optic nerve lesion. Leibowitz and Alter (1973) , however, found an opposite pattern with regard to the latter; no explanation for this discrepancy was given. A relationship between a benign prognosis and initial sensory symptoms has also been noted by several other authors (Poeck and Markus, 1964; Gudmundsson, 1971; Riser et al, 1971; Poser et al, 1982ft; Visscher et al, 1984) .
A poor prognosis has also been reported previously in those with an initial cerebellar lesion (Miiller, 1949; Bonduelle and Albaranes, 1962; Stazio etal., 1964; Gudmundsson, 1971; Kurtzke etal., 1977; Poser etal., 1982&; T. Broman, persona] communication), a spinal cord lesion (Abb and Schaltenbrand, 1956; Poser et al., 1978) , or lesions at multiple sites in the nervous system (Miller, 1949; Miiller, 1949) . As shown by others, symptoms indicative of a pyramidal tract lesion also correlated with a poor prognosis in the present study (numerical data not shown). Other symptoms which were associated with a poor prognosis, as shown by a significantly reduced survival in the part of the present sample which was observed until death, included psychiatric and urinary symptoms either at the onset or within the first 10 yrs (Phadke, 1987) . Duration of the initial symptoms had a linear relationship with the disease severity. Kurtzke et al. (1977) , during the initial analysis of their sample, also noted a similar pattern.
An inverse relationship between the prognosis and the onset to first relapse interval (O-R), as noted in the present sample, has also been observed by many others (Bonduelle and Albaranes, 1962; Riser etal., 1971; Kurtzke etal., 1977; Confavreux etal, 1980; Thompson et al., 1986) . Confavreux et al. (1980) found a mean O -R interval of 2.4 yrs in those with severe (acute) and 0.9 yrs in those with a hyperacute prognosis; in contrast, the mean O-R interval was 5.6 yrs in their benign cases.
There is almost universal agreement that patients with a progressive course from onset have a poor prognosis (Miiller, 1949; Lazarte, 1950; Thygesen, 1953; White and Wheelan, 1959; McAlpine, 1961; Poeck and Markus, 1964; Bauer et al., 1965; Bonduelle, 1967; Confavreux et al., 1980; Noseworthy et al., 1983; Verjans etal., 1983) . In the present investigation, a poor prognosis was shown not only by an early severe morbidity but also by a significantly short survival in that part of the present sample which was observed until death (Phadke, 1987) .
Correlating the CSF changes with prognosis and course of disease has proved difficult for a number of reasons (Phadke, 1985) , particularly the variable association between elevated cell counts and relapse (which at times may be clinically undetectable), the rise in the CSF protein content at the time of a relapse, and the fluctuation in the CSF IgG content and pattern of oligoclonal IgG bands at different times of the disease. Technical factors might also have been responsible for the differences between some centres. In the present study, timing of the lumbar puncture was not precisely recorded in all cases but, in general, CSF was examined during a relapse. The lack of relationship between the level of IgG (expressed as a percentage or an index), and the prognosis of the disease has also been observed by many others (Bergmann et al., 1964; Bradshaw, 1964; Bauer et al., 1965; Kurtzke et al., 1972; Schmidt et al., 1977; Christensen et al., 1978; Paty etal., 1979; Confavreux etal., 1980; Hutchinson etal., 1983; Rocchelli et al., 1983; Thompson et al., 1986) . Some authors, however, have reported a close association between raised CSF IgG concentrations and a poor prognosis (Yahr et al., 1954; Olsson etal., 1976; Stendhal-Brodin and Link, 1980; Verjans etal, 1983) . The CSF changes in the present series were unrelated to the course of the disease, except that patients with a relapsing disease had a slight but insignificantly greater cell count in their CSF.
In a recent study from Ireland, a lack of relationship between VEP PI00 latency and disease prognosis was noted in a group of 70 hospital-attending MS patients (Thompson et al., 1986) . If the significant relationship noted in the present study between a poor prognosis, a progressive course from onset and bilateral prolongation of P100 latency is confirmed, it might prove to be a useful indicator of prognosis.
The present comparison of the clinical pattern of MS in various parts of the world, in particular with regard to the age at onset, the pattern of initial symptoms, and the course and prognosis of the disease, clearly showed that differences exist not only between the eastern and western centres but also amongst the various western centres. While these clinical differences may partly be due to nonuniformity in the selection criteria, taking the entire evidence into account they do seem real. Histological differences in the CNS lesions between Caucasian and Oriental MS patients have been reported (Ikuta et al., 1982) . Two possibilities arise. The difference might be due to a variation in the genetic or immunological make-up as shown by differences in the HLA characteristics of MS patients from various parts of the world (Batchelor, 1985) , or the disease clinically identified as MS may be triggered by several different, as yet unidentified, environmental factors in different parts of the world. Further studies on comparable patient samples might prove to be of value.
In conclusion, analysis of this large unselected series of MS patients closely observed in a region under epidemiological investigation has provided valuable information about the course and prognosis of the disease and the factors influencing them. The significance of a number of previously identified prognostic factors has been confirmed and several new ones identified. The reasons for the clinical differences in different parts of the world remain uncertain and their elucidation may throw light on the aetiology of the disease.
